GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Caliber Imaging & Diagnostics Inc (OTCPK:LCDX) » Definitions » Deferred Tax

Caliber Imaging & Diagnostics (Caliber Imaging & Diagnostics) Deferred Tax : $0.00 Mil (TTM As of Mar. 2014)


View and export this data going back to 2012. Start your Free Trial

What is Caliber Imaging & Diagnostics Deferred Tax?

Change In Deferred Tax represents future tax liability or asset, resulting from temporary differences between book (accounting) value of assets and liabilities, and their tax value. This arises due to differences between financial accounting for shareholders and tax accounting.

Caliber Imaging & Diagnostics's change in deferred tax for the three months ended in Mar. 2014 was $0.00 Mil. Its change in deferred tax for the trailing twelve months (TTM) ended in Mar. 2014 was $0.00 Mil.


Caliber Imaging & Diagnostics Deferred Tax Historical Data

The historical data trend for Caliber Imaging & Diagnostics's Deferred Tax can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Caliber Imaging & Diagnostics Deferred Tax Chart

Caliber Imaging & Diagnostics Annual Data
Trend Dec09 Dec10 Dec11 Dec12 Dec13
Deferred Tax
- - - - -

Caliber Imaging & Diagnostics Quarterly Data
Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14
Deferred Tax Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Caliber Imaging & Diagnostics Deferred Tax Calculation

Change In Deferred Tax represents future tax liability or asset, resulting from temporary differences between book (accounting) value of assets and liabilities, and their tax value. This arises due to differences between financial accounting for shareholders and tax accounting.

Deferred Tax for the trailing twelve months (TTM) ended in Mar. 2014 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.


* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Caliber Imaging & Diagnostics Deferred Tax Related Terms

Thank you for viewing the detailed overview of Caliber Imaging & Diagnostics's Deferred Tax provided by GuruFocus.com. Please click on the following links to see related term pages.


Caliber Imaging & Diagnostics (Caliber Imaging & Diagnostics) Business Description

Traded in Other Exchanges
N/A
Address
100 Burtt Road, Suite 203, Andover, MA, USA, 01810
Caliber Imaging & Diagnostics Inc is a medical device company engaged in developing, manufacturing, marketing & selling point-of-care cellular imaging systems to diagnose skin cancer. It offers clinical imaging and research imaging solutions that shows tissue at the cellular level. Its products portfolio includes; VivaScope; VivaScope 3000, 1500 & 2500; and VivaNet and VivaScan.
Executives
Paul Stuka director C/O OSIRIS PARTNERS, LLC, ONE LIBERTY SQUARE, 5TH FLOOR, BOSTON MA 02109
William J Shea director, 10 percent owner 11825 N PENNSYLVANIA ST, CARMEL IN 46032
Kevin M Cronin director
Richard Christopher officer: Chief Financial Officer C/O LUCID, INC., 50 METHODIST HILL DR, SUITE 1000, ROCHESTER NY 14623
Martin Joseph Joyce officer: Chief Financial Officer 1050 HINGHAM STREET, ROCKLAND MA 02370
Matthew S Cox director 58 OAKWOOD DRIVE, CHAPEL HILL NC 27517

Caliber Imaging & Diagnostics (Caliber Imaging & Diagnostics) Headlines